Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease
Clinical trial NCT04914247 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04914247
- Sponsor
- Actelion
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.